Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra J Lansky

Showing results (371-380 of 471) with videos related to

Pageof 48
Sort By:
JACC. Cardiovascular Interventions|September 24, 2011
Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trialAdam J Saltzman, Gregg W Stone, Bimmer E Claessen, et al.
JACC. Cardiovascular Interventions|June 25, 2011
Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trialsRoxana Mehran, Stuart Pocock, Eugenia Nikolsky, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesionsRicardo A Costa, J Eduardo Sousa, Alexandre Abizaid, et al.
European Heart Journal|April 9, 2009
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trialRoxana Mehran, Stuart J Pocock, Gregg W Stone, et al.
Circulation|October 31, 2002
Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosisRoss Prpic, Paul S Teirstein, John P Reilly, et al.
JAMA|March 3, 2005
Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trialGregg W Stone, John Webb, David A Cox, et al.
Circulation. Cardiovascular Genetics|February 19, 2013
A blood-based gene expression test for obstructive coronary artery disease tested in symptomatic nondiabetic patients referred for myocardial perfusion imaging the COMPASS studyGregory S Thomas, Szilard Voros, John A McPherson, et al.
Journal of Electrocardiology|November 21, 2017
What is the best ST-segment recovery parameter to predict clinical outcome and myocardial infarct size? Amplitude, speed, and completeness of ST-segment recovery after primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionWichert J Kuijt, Cindy L Green, Niels J W Verouden, et al.
JACC. Cardiovascular Imaging|September 18, 2017
Role of Low Endothelial Shear Stress and Plaque Characteristics in the Prediction of Nonculprit Major Adverse Cardiac Events: The PROSPECT StudyPeter H Stone, Akiko Maehara, Ahmet Umit Coskun, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 3, 2019
Defining device success for percutaneous coronary intervention trials: a position statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of CardiologyChun Chin Chang, Norihiro Kogame, Yoshinobu Onuma, et al.
Pageof 48

Showing results (371-380 of 471) with videos related to

Sort By:
Pageof 48
JACC. Cardiovascular Interventions|September 24, 2011
Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trialAdam J Saltzman, Gregg W Stone, Bimmer E Claessen, et al.
JACC. Cardiovascular Interventions|June 25, 2011
Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trialsRoxana Mehran, Stuart Pocock, Eugenia Nikolsky, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesionsRicardo A Costa, J Eduardo Sousa, Alexandre Abizaid, et al.
European Heart Journal|April 9, 2009
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trialRoxana Mehran, Stuart J Pocock, Gregg W Stone, et al.
Circulation|October 31, 2002
Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosisRoss Prpic, Paul S Teirstein, John P Reilly, et al.
JAMA|March 3, 2005
Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trialGregg W Stone, John Webb, David A Cox, et al.
Circulation. Cardiovascular Genetics|February 19, 2013
A blood-based gene expression test for obstructive coronary artery disease tested in symptomatic nondiabetic patients referred for myocardial perfusion imaging the COMPASS studyGregory S Thomas, Szilard Voros, John A McPherson, et al.
Journal of Electrocardiology|November 21, 2017
What is the best ST-segment recovery parameter to predict clinical outcome and myocardial infarct size? Amplitude, speed, and completeness of ST-segment recovery after primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionWichert J Kuijt, Cindy L Green, Niels J W Verouden, et al.
JACC. Cardiovascular Imaging|September 18, 2017
Role of Low Endothelial Shear Stress and Plaque Characteristics in the Prediction of Nonculprit Major Adverse Cardiac Events: The PROSPECT StudyPeter H Stone, Akiko Maehara, Ahmet Umit Coskun, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 3, 2019
Defining device success for percutaneous coronary intervention trials: a position statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of CardiologyChun Chin Chang, Norihiro Kogame, Yoshinobu Onuma, et al.
Pageof 48